Vertex Pharmaceuticals Stock: Bull vs. Bear
Vertex Pharmaceuticals (NASDAQ: VRTX) has been a big disappointment for investors in 2021. While the S&P 500 index soared nearly 30%, Vertex's shares are down 5%.
Investors are much more focused on where a stock might be headed than where it's been in the past, though. But there are often different views on what the future holds for a given stock. That's definitely the case with Vertex. Here are both bull and bear arguments for the biotech stock.
Image source: Getty Images.
Source Fool.com
